Skip to main content
. 2023 May 9;112(11):1610–1619. doi: 10.1007/s00392-023-02221-4

Table 1.

Demographic data before initiation of therapy

ARB BB p-value
Number (n) 75 14
Gender (female) 33/ 44% 6/ 43%
Age at treatment initiation (age in years) 8.1 ± 4.8 10 ± 5.6 0.179
Follow-up period (in months) 7.5 ± 5.4 8.8 ± 5.8 0.409

ARB angiotensin receptor blocker, BB beta blocker